+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Leigh Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Leigh Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Malignant Pleural Effusion - Epidemiology Forecast to 2032 - Product Thumbnail Image

Malignant Pleural Effusion - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate To Severe Acute Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Moderate To Severe Acute Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Darbepoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Darbepoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Epoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Teriparatide- Biosimilar Insight, 2022 - Product Thumbnail Image

Teriparatide- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Rosacea - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rosacea - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
From
Rosacea - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rosacea - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Spinal Muscular Atrophy (SMA) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Spinal Muscular Atrophy (SMA) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Cold Agglutinin Disease (CAD) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Cold Agglutinin Disease (CAD) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Immune Thrombocytopenia (ITP) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Trichomoniasis - Epidemiology Forecast to 2032 (US) - Product Thumbnail Image

Trichomoniasis - Epidemiology Forecast to 2032 (US)

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US) - Product Thumbnail Image

Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US)

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more